- Intravitreal Anti-vascular Endothelial Growth Factor for Typical Exudative Age-related Macular Degeneration in Eyes with Good Baseline Visual Acuity
-
Chang YS, Han JI, Yoo SJ, Lew YJ, Kim JH
- KMID: 2345823
- Korean J Ophthalmol.
- 2014 Dec;28(6):466-472.
- doi: 10.3341/kjo.2014.28.6.466
PURPOSE: To investigate 12-month treatment outcomes of anti-vascular endothelial growth factor therapy in eyes with typical exudative age-related macular degeneration with good baseline visual acuity. METHODS: This retrospective observational case series... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Findings of Visual Outcome in Spectral Domain Optical Coherence Tomography after Ranibizumab Treatment in Age-related Macular Degeneration
-
Kwon YH, Lee DK, Kim HE, Kwon OW
- KMID: 2344262
- Korean J Ophthalmol.
- 2014 Oct;28(5):386-392.
- doi: 10.3341/kjo.2014.28.5.386
PURPOSE: To investigate which spectral domain optical coherence tomography (SD-OCT) findings predict visual outcome after anti-vascular endothelial growth factor (VEGF) treatment in neovascular age-related macular degeneration (NV-AMD). METHODS: We reviewed the... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Vitreomacular Traction on Ranibizumab Treatment Response in Eyes with Neovascular Age-related Macular Degeneration
-
Lee KH, Chin HS, Kim NR, Moon YS
- KMID: 2363847
- Korean J Ophthalmol.
- 2015 Dec;29(6):396-403.
- doi: 10.3341/kjo.2015.29.6.396
PURPOSE: To investigate the effects of vitreomacular traction (VMT) on ranibizumab treatment response for neovascular age-related macular degeneration (AMD). METHODS: A retrospective review of 85 eyes of 85 patients newly diagnosed... -
- CITED
-
- Close
- SHARE
-
- Close
